Drug Search Results
More Filters [+]

Nepadutant

Alternative Names: nepadutant
Latest Update: 2023-05-04
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: NK2 Antagonist

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Menarini
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Nepadutant

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Colic

Phase 1: Colic|Intestinal Diseases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

nocry

P2

Completed

Colic

2013-12-28

no-cry

P2

Completed

Colic

2013-12-01

nocry-a

P2

Withdrawn

Colic

2012-11-01

NOCRY-a

P2

Terminated

Colic

2012-10-15

Recent News Events

Date

Type

Title